Completed PHASE4 INTERVENTIONAL 5-arm NCT00712335

The Effects of Montelukast on Smokers With Asthma

The Effects of Montelukast on Sputum Cells and Inflammatory Markers in Smokers With Asthma

Sponsor: Inje University

Conditions Asthmatic Smokers Non-asthmatic Smokers

Interventions Fluticasone Propionate Montelukast Salmeterol

Updated 8 times since 2017 Last updated: Apr 18, 2012 Started: Feb 28, 2007 Primary completion: May 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Asthmatic Smokers and Non-asthmatic Smokers and is currently completed. Inje University leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Dec 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Inje University

Data source: Inje University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea